Crystal L. Mackall - Concepedia

Author

Crystal L. Mackall

Also Known As

C L Mackall, C Mackall, C. L Mackall, C. L. Mackall, C. Mackall, C.L. Mackall, Crystal L Mackall, Crystal L. Mackall, Crystal Lee Mackall, Crystal Mackall

485

Publications

25.4K

Citations

H-Index

132

Concepts

All Affiliations

Stanford University National Cancer Institute National Institutes of Health Center for Cancer Research Children's Hospital of Philadelphia

About

Crystal L. Mackall is an author at Stanford University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	41	10.2K
2	Engineering	4	4	538
3	Health Sciences	4	4	3.1K
4	Public Health	2	2	59
5	Natural Sciences	1	1	35

Crystal L. Mackall

122

Publications

21.8K

Citations

H-Index

Page 1

	Year	Citations
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, The Lancet T CellsT-regulatory CellImmunologyHematologyAutoimmunity	2014	2.9K
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors Adrienne H. Long, Waleed Haso, Jack F. Shern, Nature Medicine Autoimmune DiseaseTonic SignalingImmunologyAntigen ProcessingAutoimmunity	2015	1.7K
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, Journal of Clinical Oncology	2011	1.6K
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy Terry J. Fry, Nirali N. Shah, Rimas J. Orentas, Nature Medicine AllergyAutoimmune DiseaseCd19-targeted Car ImmunotherapyAdaptive Immune SystemT-regulatory Cell	2017	1.3K
c-Jun overexpression in CAR T cells induces exhaustion resistance Rachel C. Lynn, Evan W. Weber, Elena Sotillo, Nature PhysiologyAutoimmunityTolerance InductionImmunotherapyMedicine	2019	831
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy Steven L. Highfill, Yongzhi Cui, Amber Giles, Science Translational Medicine	2014	742
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors Robbie G. Majzner, Johanna Theruvath, Anandani Nellan, Clinical Cancer Research	2019	637
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling Evan W. Weber, Kevin R. Parker, Elena Sotillo, Science	2021	558
Tuning the Antigen Density Requirement for CAR T-cell Activity Robbie G. Majzner, Skyler P. Rietberg, Elena Sotillo, Cancer Discovery	2020	537
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant, Cancer Discovery	2018	418

Page 1